126 related articles for article (PubMed ID: 12620651)
1. Genetic polymorphisms of osteopontin in association with multiple sclerosis in Japanese patients.
Niino M; Kikuchi S; Fukazawa T; Yabe I; Tashiro K
J Neuroimmunol; 2003 Mar; 136(1-2):125-9. PubMed ID: 12620651
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin polymorphisms and disease course in multiple sclerosis.
Caillier S; Barcellos LF; Baranzini SE; Swerdlin A; Lincoln RR; Steinman L; Martin E; Haines JL; Pericak-Vance M; Hauser SL; Oksenberg JR;
Genes Immun; 2003 Jun; 4(4):312-5. PubMed ID: 12761568
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of the osteopontin gene and clinical course of multiple sclerosis in the Polish population.
Biernacka-Lukanty J; Michalowska-Wender G; Michalak S; Raczak B; Kozubski W; Urbanski D; Wender M
Folia Neuropathol; 2015; 53(4):343-6. PubMed ID: 26785368
[TBL] [Abstract][Full Text] [Related]
4. Association of polymorphisms in CTLA-4, IL-1ra and IL-1beta genes with multiple sclerosis in Serbian population.
Dincić E; Zivković M; Stanković A; Obradović D; Alavantić D; Kostić V; Raicević R
J Neuroimmunol; 2006 Aug; 177(1-2):146-50. PubMed ID: 16769128
[TBL] [Abstract][Full Text] [Related]
5. A study of interleukin-1 cluster genes in susceptibility to and severity of multiple sclerosis.
Luomala M; Lehtimäki T; Elovaara I; Wang X; Ukkonen M; Mattila K; Laippala P; Koivula T; Hurme M
J Neurol Sci; 2001 Apr; 185(2):123-7. PubMed ID: 11311293
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms of IL-1beta and IL-1 receptor antagonist in association with multiple sclerosis in Japanese patients.
Niino M; Kikuchi S; Fukazawa T; Yabe I; Sasaki H; Tashiro K
J Neuroimmunol; 2001 Aug; 118(2):295-9. PubMed ID: 11498264
[TBL] [Abstract][Full Text] [Related]
7. Sequence variants of the secreted phosphoprotein 1 gene are associated with total serum immunoglobulin E levels in a Japanese population.
Tanino Y; Hizawa N; Konno S; Fukui Y; Takahashi D; Maeda Y; Huang SK; Nishimura M
Clin Exp Allergy; 2006 Feb; 36(2):219-25. PubMed ID: 16433860
[TBL] [Abstract][Full Text] [Related]
8. Intercellular adhesion molecule-1 gene polymorphism in Iranian patients with multiple sclerosis.
Mousavi SA; Nikseresht AR; Arandi N; Borhani Haghighi A; Ghaderi A
Eur J Neurol; 2007 Dec; 14(12):1397-9. PubMed ID: 17868277
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin gene haplotypes correlate with multiple sclerosis development and progression.
Chiocchetti A; Comi C; Indelicato M; Castelli L; Mesturini R; Bensi T; Mazzarino MC; Giordano M; D'Alfonso S; Momigliano-Richiardi P; Liguori M; Zorzon M; Amoroso A; Trojano M; Monaco F; Leone M; Magnani C; Dianzani U
J Neuroimmunol; 2005 Jun; 163(1-2):172-8. PubMed ID: 15885319
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor gene polymorphism in Japanese patients with multiple sclerosis.
Niino M; Kikuchi S; Fukazawa T; Yabe I; Tashiro K
J Neurol Sci; 2000 Oct; 179(S 1-2):70-5. PubMed ID: 11054488
[TBL] [Abstract][Full Text] [Related]
11. Progression of multiple sclerosis is associated with exon 1 CTLA-4 gene polymorphism.
Bilińska M; Frydecka I; Noga L; Dobosz T; Zołedziewska M; Suwalska K; Tutak A; Pokryszko-Dragan A
Acta Neurol Scand; 2004 Jul; 110(1):67-71. PubMed ID: 15180809
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin gene and clinical severity of multiple sclerosis.
Hensiek AE; Roxburgh R; Meranian M; Seaman S; Yeo T; Compston DA; Sawcer SJ
J Neurol; 2003 Aug; 250(8):943-7. PubMed ID: 12928913
[TBL] [Abstract][Full Text] [Related]
13. Genetic association between polymorphisms in the BTG1 gene and multiple sclerosis.
Camiña-Tato M; Morcillo-Suárez C; Navarro A; Fernández M; Horga A; Montalban X; Comabella M
J Neuroimmunol; 2009 Aug; 213(1-2):142-7. PubMed ID: 19515430
[TBL] [Abstract][Full Text] [Related]
14. CTLA4 is associated with susceptibility to multiple sclerosis.
Kantarci OH; Hebrink DD; Achenbach SJ; Atkinson EJ; Waliszewska A; Buckle G; McMurray CT; de Andrade M; Hafler DA; Weinshenker BG
J Neuroimmunol; 2003 Jan; 134(1-2):133-41. PubMed ID: 12507781
[TBL] [Abstract][Full Text] [Related]
15. A polymorphism of the osteopontin gene is related to urinary calcium stones.
Gao B; Yasui T; Okada A; Tozawa K; Hayashi Y; Kohri K
J Urol; 2005 Oct; 174(4 Pt 1):1472-6. PubMed ID: 16145474
[TBL] [Abstract][Full Text] [Related]
16. The association between functional HLA-G 14bp insertion/deletion and +3142 C>G polymorphisms and susceptibility to multiple sclerosis.
Ben Fredj N; Sakly K; Bortolotti D; Aissi M; Frih-Ayed M; Rotola A; Caselli E; Cura F; Sakly N; Aouni M; Di Luca D; Rizzo R
Immunol Lett; 2016 Dec; 180():24-30. PubMed ID: 27771469
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of osteopontin in rheumatoid synovial mononuclear cells is associated with joint inflammation, not with genetic polymorphism.
Xu G; Sun W; He D; Wang L; Zheng W; Nie H; Ni L; Zhang D; Li N; Zhang J
J Rheumatol; 2005 Mar; 32(3):410-6. PubMed ID: 15742430
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin and interleukin-17A genes polymorphisms in Egyptian systemic lupus erythematosus patients: A relation to disease activity and severity.
Pasha HF; Tantawy EA; Youssef MA
Gene; 2019 Jun; 702():107-113. PubMed ID: 30898714
[TBL] [Abstract][Full Text] [Related]
19. Investigation of bax, bcl-2, bcl-x and p53 gene polymorphisms in multiple sclerosis.
Kuhlmann T; Glas M; zum Bruch C; Mueller W; Weber A; Zipp F; Brück W
J Neuroimmunol; 2002 Aug; 129(1-2):154-60. PubMed ID: 12161031
[TBL] [Abstract][Full Text] [Related]
20. Association between Synapsin III gene promoter polymorphisms and multiple sclerosis.
Liguori M; Cittadella R; Manna I; Valentino P; La Russa A; Serra P; Trojano M; Messina D; Ruscica F; Andreoli V; Romeo N; Livrea P; Quattrone A
J Neurol; 2004 Feb; 251(2):165-70. PubMed ID: 14991350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
